Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Anesthesiology
Published in: BMC Anesthesiology 1/2020

Open Access 01-12-2020 | Septicemia | Research article

AChE-activity in critically ill patients with suspected septic encephalopathy: a prospective, single-centre study

Authors: Benedikt Zujalovic, Benjamin Mayer, Sebastian Hafner, Florian Balling, Eberhard Barth

Published in: BMC Anesthesiology | Issue 1/2020

Login to get access

Abstract

Background

Up to 70% of septic patients develop a diffuse brain dysfunction named “septic associated encephalopathy” which is often solely based on clinical impressions. However, the diagnosis of septic associated encephalopathy is outcome-relevant due to an increase in mortality in these patients. Neuroinflammation as well as a disturbance of cholinergic transmission are assumed to be the causes of both delirium and septic associated encephalopathy. An alteration in cholinergic activity can be objectified by measuring the erythrocytic acetylcholinesterase-activity. Single-point measurements of acetylcholinesterase-activity are of limited value because individual and dynamic changes over time have to be anticipated. Therefore, the hypothesis should be tested whether a longitudinal analysis of acetylcholinesterase-activity in critically ill patients can help to diagnose a suspected septic-associated encephalopathy and whether acetylcholinesterase-activity differs in comparison to non-septic patients.

Methods

In this prospective, observational, single-center study, 175 patients (45 with sepsis, 130 without sepsis) were included. All patients were admitted to the surgical Intensive Care Unit of the University hospital Ulm, Germany. Patients were examined daily for the presence of delirium using the CAM-ICU. Daily measurement of the acetylcholinesterase-activity was performed in all patients. The possible time-dependent change in acetylcholinesterase-activity was analyzed with a linear regression model considering repeated measurements. Using a time-adjusted model further factors able to affect AChE-activity were investigated. For nonparametric distributions quantitative data were compared using Wilcoxon matched-pairs test. For analysis of independent samples the Mann-Whitney test was performed.

Results

About 90% of septic patients with suspected septic associated encephalopathy exhibited a statistically significant time-dependent in- or decrease in acetylcholinesterase-activity over a period of at least 5 consecutive days.

Conclusion

Longitudinal measurement of acetylcholinesterase-activity over several consecutive days revealed a change from baseline only in septic patients with suspected septic-associated encephalopathy. Therefore, longitudinal measurement of acetylcholinesterase-activity is able to diagnose septic associated encephalopathy in septic patients with delirious symptoms.

Trial registration

Retrospectively registered at German Clinical Trials Register, registration number DRKS00020542, date of registration: January 27, 2020.
Literature
1.
Bracht H, Hafner S, Weiß M. Sepsis-update: definition und Epidemiologie. Anasthesiol Intensivmed Notfallmed Schmerzther. 2019;54(01):10–20.PubMedCrossRef
2.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.PubMedPubMedCentralCrossRef
3.
Andonegui G, Zelinski EL, Schubert CL, Knight D, Craig LA, Winston BW, et al. Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment. JCI Insight. 2018;3:9.CrossRef
4.
Young GB. Encephalopathy of infection and systemic inflammation. J Clin Neurophysiol. 2013 Oct;30(5):454–61.PubMedCrossRef
5.
Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, Sheagren JN, et al. Impact of encephalopathy on mortality in the sepsis syndrome. The veterans administration systemic sepsis cooperative study group. Crit Care Med. 1990;18(8):801–6.PubMedCrossRef
6.
7.
Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci. 2008;63(7):764–72.PubMedCrossRef
8.
Steiner LA. Postoperative delirium. Part 1: pathophysiology and risk factors. Eur J Anaesthesiol. 2011;28(9):628–36.PubMedCrossRef
9.
Pandharipande P, Cotton BA, Shintani A, Thompson J, Pun BT, Morris JA, et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma. 2008;65(1):34–41.PubMedPubMedCentralCrossRef
10.
Chaiwat O, Chanidnuan M, Pancharoen W, Vijitmala K, Danpornprasert P, Toadithep P, et al. Postoperative delirium in critically ill surgical patients: incidence, risk factors, and predictive scores. BMC Anesthesiol. 2019;19(1):39.PubMedPubMedCentralCrossRef
11.
12.
Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry. 2000;5(2):132–48.PubMed
13.
Semmler A, Frisch C, Debeir T, Ramanathan M, Okulla T, Klockgether T, et al. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol. 2007;204(2):733–40.PubMedCrossRef
14.
Ballinger EC, Ananth M, Talmage DA, Role LW. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron. 2016;91(6):1199–218.PubMedPubMedCentralCrossRef
15.
Abou-Hatab K, O’Mahony M, Patel S, Carey D, Woodhouse K. Plasma esterase activities in young and old patients undergoing open inguinal hernia repair. Arch Gerontol Geriatr. 2000;31(3):193–8.PubMedCrossRef
16.
17.
Weismüller K, Bauer M, Hofer S, Weigand M. Sepsis – die Bedeutung der neuroendokrinen Achse in der Pathophysiologie der sepsis. Anasthesiol Intensivmed Notfallmed Schmerzther. 2010;45(09):574–9.PubMedCrossRef
18.
Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, et al. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis*. Crit Care Med. 2008;36(2):404–8.PubMedCrossRef
19.
Zivkovic AR, Sedlaczek O, von Haken R, Schmidt K, Brenner T, Weigand MA, et al. Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity. Acta Neuropathol Commun. 2015;3:1.CrossRef
20.
Bitzinger DI, Gruber M, Tümmler S, Malsy M, Seyfried T, Weber F, et al. In vivo effects of neostigmine and Physostigmine on neutrophil functions and evaluation of Acetylcholinesterase and Butyrylcholinesterase as inflammatory markers during experimental sepsis in rats. Mediat Inflamm. 2019;2019:1–12.CrossRef
21.
van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet. 2010;375(9716):773–5.PubMedCrossRef
22.
Zaghloul N, Addorisio ME, Silverman HA, Patel HL, Valdés-Ferrer SI, Ayasolla KR, et al. Forebrain cholinergic dysfunction and systemic and brain inflammation in murine sepsis survivors. Front Immunol. 2017;8:1673.PubMedPubMedCentralCrossRef
23.
Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med Camb Mass. 2003;9(5–8):125–34.PubMedPubMedCentral
24.
Santarpia L, Grandone I, Contaldo F, Pasanisi F. Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachexia Sarcopenia Muscle. 2013;4(1):31–9.PubMedCrossRef
25.
Thomsen T, Kaden B, Fischer JP, Bickel U, Barz H, Gusztony G, et al. Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine. Eur J Clin Chem Clin Biochem J Forum Eur Clin Chem Soc. 1991;29(8):487–92.
26.
Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta. 1999;288(1–2):73–90.PubMedCrossRef
27.
Barth E, Bracht H, Georgieff M, Zujalovic B. AChE- und BChE-Aktivität als Entscheidungshilfe für die medikamentöse Therapie von Delir und kognitiver Dysfunktion bei Intensivpatienten. Barth E Bracht H Georgieff M Zujalovic B AChE- BChE-Akt Als Entscheid Für Medikam Ther Von Delir Kognitiver Dysfunktion Bei Intensiv. 2019;5–2019:233–42.
28.
Chaudhry N, Duggal AK. Sepsis associated encephalopathy. Adv Med. 2014;2014:1–16.CrossRef
29.
Krewulak KD, Stelfox HT, Leigh JP, Ely EW, Fiest KM. Incidence and prevalence of delirium subtypes in an adult ICU: a systematic review and meta-analysis*. Crit Care Med. 2018;46(12):2029–35.PubMedCrossRef
30.
Terborg C. Septic encephalopathy. Med Klin Intensivmed Notfallmedizin. 2012;107(8):629–33.CrossRef
31.
Lacobone E, Bailly-Salin J, Polito A, Friedman D, Stevens RD, Sharshar T. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med. 2009;37:10.CrossRef
32.
Adam EH, Haas V, Lindau S, Zacharowski K, Scheller B. Cholinesterase alterations in delirium after cardiosurgery: a German monocentric prospective study. BMJ Open. 2020;10(1):e031212.PubMedPubMedCentralCrossRef
33.
Berg RMG, Møller K, Bailey DM. Neuro-oxidative-nitrosative stress in sepsis. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2011;31(7):1532–44.CrossRef
34.
Maldonado JR. Delirium pathophysiology: an updated hypothesis of the etiology of acute brain failure. Int J Geriatr Psychiatry. 2018;33(11):1428–57.PubMedCrossRef
35.
Méndez-Garrido A, Hernández-Rodríguez M, Zamorano-Ulloa R, Correa-Basurto J, Mendieta-Wejebe JE, Ramírez-Rosales D, et al. In vitro effect of H2O 2, some transition metals and hydroxyl radical produced via Fenton and Fenton-like reactions, on the catalytic activity of AChE and the hydrolysis of ACh. Neurochem Res. 2014;39(11):2093–104.PubMedCrossRef
36.
Cerejeira J, Batista P, Nogueira V, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB. Low preoperative plasma cholinesterase activity as a risk marker of postoperative delirium in elderly patients. Age Ageing. 2011;40(5):621–6.PubMedCrossRef
37.
Müller A, Olbert M, Heymann A, Zahn PK, Plaschke K, von Dossow V, et al. Relevance of peripheral cholinesterase activity on postoperative delirium in adult surgical patients (CESARO): a prospective observational cohort study. Eur J Anaesthesiol. 2019;36(2):114–22.PubMedCrossRef
38.
John M, Ely EW, Halfkann D, Schoen J, Sedemund-Adib B, Klotz S, et al. Acetylcholinesterase and butyrylcholinesterase in cardiosurgical patients with postoperative delirium. J Intensive Care. 2017;5(1):29.PubMedPubMedCentralCrossRef
39.
Zivkovic AR, Schmidt K, Sigl A, Decker SO, Brenner T, Hofer S. Reduced serum Butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients. Mediat Inflamm. 2015;2015:1–11.CrossRef
40.
Hajjawi OS. Acetylcholinesterase in human red blood cells. Eur J Sci Res. 2012;75(4):510–22.
41.
Gamberini M, Bolliger D, Lurati Buse GA, Burkhart CS, Grapow M, Gagneux A, et al. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial. Crit Care Med. 2009;37(5):1762–8.PubMedCrossRef
42.
Liptzin B, Laki A, Garb JL, Fingeroth R, Krushell R. Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry. 2005;13(12):1100–6.PubMedCrossRef
43.
Field RH, Gossen A, Cunningham C. Prior pathology in the basal forebrain cholinergic system predisposes to inflammation-induced working memory deficits: reconciling inflammatory and cholinergic hypotheses of delirium. J Neurosci. 2012;32(18):6288–94.PubMedPubMedCentralCrossRef
Metadata
Title
AChE-activity in critically ill patients with suspected septic encephalopathy: a prospective, single-centre study
Authors
Benedikt Zujalovic
Benjamin Mayer
Sebastian Hafner
Florian Balling
Eberhard Barth
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2020
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-020-01204-6

Other articles of this Issue 1/2020

BMC Anesthesiology 1/2020 Go to the issue

Research article

Intraoperative ventilation strategies for obese patients undergoing bariatric surgery: systematic review and meta-analysis

Research article

Dexmedetomidine versus midazolam on cough and recovery quality after partial and total laryngectomy – a randomized controlled trial

Research article

Objective validation of YouTube™ educational videos for the instruction of regional anesthesia nerve blocks: a novel approach

Research article

Intraoperative mechanical ventilation practice in thoracic surgery patients and its association with postoperative pulmonary complications: results of a multicenter prospective observational study

Research article

Perioperative non-invasive versus semi-invasive cardiac index monitoring in patients with bariatric surgery – a prospective observational study

Research article

Single nucleotide polymorphisms associated with postoperative inadequate analgesia after single-port VATS in Chinese population